{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:56:40Z","timestamp":1790841400744,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Dis Travel Med Vaccines"],"DOI":"10.1186\/s40794-026-00318-y","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:19:04Z","timestamp":1790767144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the impact of routine malaria vaccination on total disease burden in Cameroon: a nationwide difference\u2011in\u2011differences analysis using health district surveillance data (2023\u20132025)"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-9842","authenticated-orcid":false,"given":"Cavin Epie","family":"Bekolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Ngouenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Laura Nyame","family":"Dipepa Nwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Ewane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"318_CR1","unstructured":"Fact sheet about malaria [Internet]. [cited 2026 Mar 17]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/malaria. Accessed 17 Mar 2026."},{"key":"318_CR2","doi-asserted-by":"publisher","unstructured":"Venkatesan P. The 2023 WHO World malaria report. Lancet Microbe. 2024;5(3). https:\/\/doi.org\/10.1016\/S2666-5247(24)00016-8.","DOI":"10.1016\/S2666-5247(24)00016-8"},{"key":"318_CR3","unstructured":"Minist\u00e8re de la Sant\u00e9. Publique du Cameroun. Plan Strat\u00e9gique National de Lutte contre le Paludisme 2024\u20132028. Yaounde; 2024 Juil."},{"key":"318_CR4","doi-asserted-by":"publisher","unstructured":"Kedakse TSNJ, Kaba M 2, Baonga SF, Mboussou F, Njoh AA, Amani A, et al. Evaluation of the first malaria vaccine introduction: ongoing learning opportunities during the introduction into routine immunisation in Cameroon. BMJ Glob Health [Internet]. BMJ Publishing Group Ltd; 2026. [cited 2026 July 9];11. https:\/\/doi.org\/10.1136\/bmjgh-2024-017315.","DOI":"10.1136\/bmjgh-2024-017315"},{"key":"318_CR5","unstructured":"World Health Organization. Malaria vaccine: WHO position paper. Geneva: Weekly epidemiological record; 2022 [cited 2026 Apr 19];97. https:\/\/www.who.int\/publications\/i\/item\/who-wer9709-61-80. Accessed 19 Apr 2026."},{"key":"318_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"RTS,S Clinical Trials Partnership","year":"2015","unstructured":"RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet Lond Engl. 2015;386:31\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(15)60721-8.","journal-title":"Lancet Lond Engl"},{"key":"318_CR7","doi-asserted-by":"publisher","first-page":"e1001685","DOI":"10.1371\/journal.pmed.1001685","volume":"11","author":"RTS,S Clinical Trials Partnership","year":"2014","unstructured":"RTS,S Clinical Trials Partnership. Efficacy and safety of the RTS,S\/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014;11:e1001685. https:\/\/doi.org\/10.1371\/journal.pmed.1001685.","journal-title":"PLoS Med"},{"key":"318_CR8","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/S0140-6736(24)00004-7","volume-title":"Feasibility, safety, and impact of the RTS,S\/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi","author":"KP Asante","year":"2024","unstructured":"Asante KP, Mathanga DP, Milligan P, Akech S, Oduro A, Mwapasa V, et al. Feasibility, safety, and impact of the RTS,S\/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi. Volume 403. London, England: Lancet; 2024. pp. 1660\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(24)00004-7."},{"key":"318_CR9","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/S2214-109X(25)00415-2","volume":"14","author":"L Ndeketa","year":"2026","unstructured":"Ndeketa L, Haine V, Debois M, Asante KP, Agyapong PD, Kaali S, et al. Effectiveness of the RTS,S\/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi. Lancet Glob Health. 2026;14:e61\u20139. https:\/\/doi.org\/10.1016\/S2214-109X(25)00415-2.","journal-title":"Lancet Glob Health"},{"key":"318_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12936-023-04544-z","volume":"22","author":"NAK Chouakeu","year":"2023","unstructured":"Chouakeu NAK, Tchuinkam T, Bamou R, Bindamu MM, Talipouo A, Kopya E, et al. Malaria transmission pattern across the Sahelian, humid savanna, highland and forest eco-epidemiological settings in Cameroon. Malar J. 2023;22:116. https:\/\/doi.org\/10.1186\/s12936-023-04544-z.","journal-title":"Malar J"},{"key":"318_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/vaccines12040346","volume":"12","author":"ST Ndoula","year":"2024","unstructured":"Ndoula ST, Mboussou F, Njoh AA, Nembot R, Baonga SF, Njinkeu A, et al. Malaria Vaccine Introduction in Cameroon: Early Results 30 Days into Rollout. Vaccines. Multidisciplinary Digit Publishing Inst. 2024;12:346. https:\/\/doi.org\/10.3390\/vaccines12040346.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"318_CR12","unstructured":"PMI Measure Malaria. \u00c9valuation du syst\u00e8me de surveillance du paludisme au Cameroun: Rapport final \u2013 Malaria [Internet]. North Carolina. 2021. https:\/\/measuremalaria.cpc.unc.edu\/publications\/evaluation-du-systeme-de-surveillance-du-paludisme-au-cameroun-rapport-final\/. Accessed 19 Apr 2026."},{"key":"318_CR13","doi-asserted-by":"publisher","unstructured":"Gertler P, Martinez S, Rawlings LB, Premand P, Vermeersch CMJ. Impact evaluation in practice: second edition. IDB Publications [Internet]. Inter-American Development Bank; 2016 [cited 2026 Apr 19]. https:\/\/doi.org\/10.18235\/0006529.","DOI":"10.18235\/0006529"},{"key":"318_CR14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.39339.610000.BE","volume":"335","author":"MDE Goodyear","year":"2007","unstructured":"Goodyear MDE, Krleza-Jeric K, Lemmens T. The Declaration of Helsinki. BMJ. 2007;335:624\u20135. https:\/\/doi.org\/10.1136\/bmj.39339.610000.BE.","journal-title":"BMJ"},{"key":"318_CR15","doi-asserted-by":"publisher","unstructured":"Deaton A, Cartwright N. Understanding and misunderstanding randomized controlled trials. Soc Sci Med. 2018;210:2\u201321. https:\/\/doi.org\/10.1016\/j.socscimed.2017.12.005.","DOI":"10.1016\/j.socscimed.2017.12.005"},{"key":"318_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/ije\/26.1.224","volume":"26","author":"CG Victora","year":"1997","unstructured":"Victora CG, Huttly SR, Fuchs SC, Olinto MT. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol. 1997;26:224\u20137. https:\/\/doi.org\/10.1093\/ije\/26.1.224.","journal-title":"Int J Epidemiol"},{"key":"318_CR17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","volume":"385","author":"D Chandramohan","year":"2021","unstructured":"Chandramohan D, Zongo I, Sagara I, Cairns M, Yerbanga R-S, Diarra M, et al. Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention. New Engl J Med Mass Med Soc. 2021;385:1005\u201317. https:\/\/doi.org\/10.1056\/NEJMoa2026330.","journal-title":"New Engl J Med Mass Med Soc"},{"key":"318_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1473-3099(23)00368-7","volume":"24","author":"A Dicko","year":"2024","unstructured":"Dicko A, Ouedraogo J-B, Zongo I, Sagara I, Cairns M, Yerbanga RS, et al. Seasonal vaccination with RTS,S\/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial. Lancet Infect Dis. 2024;24:75\u201386. https:\/\/doi.org\/10.1016\/S1473-3099(23)00368-7.","journal-title":"Lancet Infect Dis"},{"key":"318_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12916-022-02536-5","volume":"20","author":"M Cairns","year":"2022","unstructured":"Cairns M, Barry A, Zongo I, Sagara I, Yerbanga SR, Diarra M, et al. The duration of protection against clinical malaria provided by the combination of seasonal RTS,S\/AS01E vaccination and seasonal malaria chemoprevention versus either intervention given alone. BMC Med. 2022;20:352. https:\/\/doi.org\/10.1186\/s12916-022-02536-5.","journal-title":"BMC Med"},{"key":"318_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/vaccines12020111","volume":"12","author":"AA Adamu","year":"2024","unstructured":"Adamu AA, Jalo RI, Ndwandwe D, Wiysonge CS. Assessing the Implementation Determinants of Pilot Malaria Vaccination Programs in Ghana, Kenya, and Malawi through a Complexity Lens: A Rapid Review Using a Consolidated Framework for Implementation Research. Vaccines (Basel). 2024;12:111. https:\/\/doi.org\/10.3390\/vaccines12020111.","journal-title":"Vaccines (Basel)"},{"key":"318_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-026-05881-5","author":"GJ Gbaguidi","year":"2026","unstructured":"Gbaguidi GJ, Loum MA, Gning LD, Tahiho AK, Diallo EM, Koutou O, et al. Assessing the potential impact of the RTS,S\/ASO1 vaccine on malaria burden in Benin: a mathematical modelling approach. Malar J [Internet]. 2026. https:\/\/doi.org\/10.1186\/s12936-026-05881-5. [cited 2026 Apr 19].","journal-title":"Malar J [Internet]"}],"container-title":["Tropical Diseases, Travel Medicine and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40794-026-00318-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-026-00318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-026-00318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:18Z","timestamp":1790838558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40794-026-00318-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1186\/s40794-026-00318-y","relation":{},"ISSN":["2055-0936"],"issn-type":[{"value":"2055-0936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The data were anonymised routine surveillance data. No individual patient information was accessed. According to national ethics guidelines, secondary analysis of aggregated programme data does not require ethical approval. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"34"}}